RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.

Clinical trial NCT02746744 · COMPLETED

Trial details

NCT number: NCT02746744
Sponsor: Anders Svenningsson
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2016-05-01
Primary completion: 2021-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.